Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Norepinephrine involvement in antidepressant action.

A Frazer1

  • 1Department of Pharmacology, The University of Texas Health Science Center at San Antonio and South Texas Veterans Health Care System, USA. frazer@uthscsa.edu

The Journal of Clinical Psychiatry
|July 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

I-wave periodicity transcranial magnetic stimulation (iTMS) on corticospinal excitability. A systematic review of the literature.

Neuroscience·2016
Same author

Role of TrkB in the anxiolytic-like and antidepressant-like effects of vagal nerve stimulation: Comparison with desipramine.

Neuroscience·2016
Same author

Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.

Molecular psychiatry·2015
Same author

Characterization of 5-HT(₁A,B) and 5-HT(₂A,C) serotonin receptor binding.

Current protocols in pharmacology·2011
Same author

Prenatal stress induces long term stress vulnerability, compromising stress response systems in the brain and impairing extinction of conditioned fear after adult stress.

Neuroscience·2011
Same author

The effect of suramin on the resorption of bovine nasal cartilage.

Inflammopharmacology·2007
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Selective serotonin reuptake inhibitors (SSRIs) overshadowed norepinephrine research. This review highlights norepinephrine reuptake inhibitors as potential antidepressants, discussing their acute and long-term effects on neurotransmitter systems.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • The popularity of selective serotonin reuptake inhibitors (SSRIs) has led to a research focus on serotonin, potentially at the expense of norepinephrine.
  • Selective norepinephrine reuptake inhibitors have shown antidepressant potential for decades, yet remain less explored than SSRIs.

Purpose of the Study:

  • To review the acute pharmacologic effects of selective reuptake inhibitors that contribute to antidepressant efficacy.
  • To discuss the long-term effects of selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (NRIs) on neurotransmitter systems.
  • To explore the potential of enhancing central noradrenergic transmission for treating depression.

Main Methods:

  • Review of existing literature on the acute and long-term pharmacologic effects of SSRIs and NRIs.

Related Experiment Videos

  • Analysis of the predictive relationship between acute drug profiles and long-term treatment outcomes.
  • Speculative discussion on the therapeutic potential of noradrenergic system modulation in depression.

    • Main Results:

    • Acute pharmacologic profiles of selective reuptake inhibitors often predict their long-term effects.
    • Long-term SSRI administration impacts serotonergic systems but not noradrenergic ones.
    • Long-term NRI administration affects noradrenergic parameters without altering serotonergic indices.

    Conclusions:

    • Selective norepinephrine reuptake inhibitors represent a viable class of antidepressants with distinct long-term effects compared to SSRIs.
    • Understanding the differential long-term effects of SSRIs and NRIs is crucial for optimizing antidepressant therapy.
    • Enhancing central noradrenergic transmission is a promising avenue for developing novel depression treatments.